Related Experiment Video
Updated: Nov 19, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
[CME: Hypertension and the COVID-19 Pandemic: What to Consider in Medical Practice]
Grégoire Wuerzner1, Bernard Waeber2
1Service de Néphrologie et Hypertension, CHUV, Lausanne.
Insights
Hypertensive patients face no increased risk of severe COVID-19 complications. Current treatments, including renin-angiotensin system blockers, and COVID-19 vaccines are safe for managing high blood pressure during the pandemic.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- The COVID-19 pandemic poses significant public health challenges.
- Certain populations, including older adults and those with diabetes, obesity, or hypertension, are at higher risk for severe complications.
Purpose of the Study:
- To evaluate the specific risks associated with COVID-19 for patients with hypertension.
- To assess the safety of current hypertension treatments and COVID-19 vaccines in this patient group.
Main Methods:
- Review of existing observational data and clinical findings related to COVID-19 in hypertensive patients.
- Analysis of treatment strategies, including renin-angiotensin system blockers.
- Assessment of COVID-19 vaccine safety in individuals with high blood pressure.
Main Results:
- Current data suggest that hypertensive patients, whether treated or not, do not face a confirmed increased risk of severe COVID-19 outcomes.
- Renin-angiotensin system blockers appear safe for use in hypertensive patients during the pandemic.
- COVID-19 vaccination is considered safe for individuals with hypertension.
Conclusions:
- There is currently no evidence to necessitate changes in the routine care of hypertensive patients due to the COVID-19 pandemic.
- Management of hypertension should continue as usual, incorporating safe treatment options and vaccination.
Abstract:
CME: Hypertension and the COVID-19 Pandemic: What to Consider in Medical Practice Abstract. The COVID-19 pandemic represents a major public health problem. A fraction of the population is at increased risk of developing complications of this disease, in particular older subjects as well as diabetic, obese and hypertensive patients. With regard to patients with high blood pressure, the existence of an increased risk remains to be confirmed in large controlled trials. So far the findings regarding this question are reassuring, whether these patients are treated or not. There seems to be no reason to worry when using blockers of the renin-angiotensin system. The observations available to date suggest that COVID-19 vaccine can be administered safely to hypertensive patients. In conclusion, there is no reason to implement changes in the care of hypertensive patients due to the pandemic.
More Related Videos
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management
Hypertension III: Clinical Manifestations and Diagnostic Studies
Special considerations while measuring blood pressure
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
Factors affecting Blood pressure
Physiological Factors:
Hypertension and Regulation of Blood Pressure

